Glycogen storage disease type XIV in the Middle East and North Africa region: A case report

doi:10.5409/wjcp.v15.i3.117375

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

(2)

(0)

(17)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Pediatr. Sep 9, 2026; 15(3): 117375
Published online Sep 9, 2026. doi: 10.5409/wjcp.v15.i3.117375

Glycogen storage disease type XIV in the Middle East and North Africa region: A case report

Khalid Adel Al Dojan, Samia Aziz Sulaiman, Abdallah Alaarag

Khalid Adel Al Dojan, Department of General Pediatrics, Maternity and Children’s Hospital at Al Bashir Hospital, Ministry of Health, Basheer Hospitals, Amman 11183, Jordan

Samia Aziz Sulaiman, School of Medicine, The University of Jordan, Amman 11942, Jordan

Abdallah Alaarag, HCA Florida Healthcare/University of South Florida Morsani College of Medicine, Citrus Hospital, Inverness, FL 34452, United States

Author contributions: Al Dojan KA, Sulaiman SA, and Alaarag A conceptualized the study, drafted the initial manuscript, and reviewed and revised the manuscript; Al Dojan KA and Sulaiman SA collected data; Al Dojan KA designed the study.

Informed consent statement: Written informed consent was obtained from the patient’s guardians for publication of this case report, including accompanying clinical and radiologic images.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).

Corresponding author: Samia Aziz Sulaiman, MD, School of Medicine, The University of Jordan, Queen Rania Street, Amman 11942, Jordan. samia.sulaiman2003@gmail.com

Received: December 10, 2025
Revised: January 17, 2026
Accepted: March 10, 2026
Published online: September 9, 2026
Processing time: 238 Days and 15.8 Hours

Core Tip

Core Tip: Phosphoglucomutase-1 deficiency is a rare, under-recognized disorder with a broad and often subtle multisystem presentation. The condition was first recognized in 1963 through paternity testing and later classified as glycogen storage disease type XIV after reports of glycogen accumulation, severe enzyme deficiency, and rhabdomyolysis. This case underscores the importance of considering phosphoglucomutase-1 deficiency in children with unexplained hepatic dysfunction, hypoglycemia, neuromuscular symptoms, and congenital anomalies, and highlights the diagnostic value of early genomic testing.